LIFE INSURERS CUT THROUGH THE SMOKE TO BRING VAPING UNDER SCRUTINY
▶ Insurers have generally treated smokers and vapers the same but reinsurers are now re-examining policies
Global reinsurers are stepping up their warnings to life insurer clients about the potential risks of vaping, putting pressure on underwriters to charge certain vapers higher rates than smokers, or even exclude them altogether.
US authorities said last month that there had been 47 deaths this year from a lung illness tied to vaping. Health concerns about vaping have grown despite evidence showing e-cigarettes help smokers to quit, and has led to bans in some countries including India and Brazil.
Most insurers have long treated smokers and vapers the same, meaning they can pay close to double the premiums of non-smokers or non-vapers. But three major reinsurers have provided updated advice on vaping in the past three months, with new warnings, while others are considering their approach.
The new warnings focus on young vapers and the vaping of liquids containing marijuana ingredient THC (tetrahydrocannabinol), which is legal and prevalent in some US states and has been linked to lung illnesses in the country.
The shift in the reinsurance and insurance sector represents a further blow to the vaping industry, which markets its products as healthier alternatives to smoking.
Hannover RE, which already advised life insurers to treat vapers like smokers, has asked them to be particularly cautious about insuring people aged under 25 following the “epidemic” of lung injuries in the US, says Nico van Zyl, the reinsurer’s US medical director.
The question of whether to offer coverage to this higher risk group should be a consideration for life insurers, he said.
French reinsurer Scor said in a paper on October 24 that e-cigarettes contain nicotine, which may have toxic effects, including on brain development in teenagers and young adults.
Scor recommends life insurers treat vaping like smoking, and exclude individuals who use vaping products considered by US authorities likely to cause lung issues – namely, those containing THC.
Swiss Re also treats vapers like smokers. In addition, its global chief medical officer John Schoonbee says the reinsurer has told insurers in recent months to make extra checks on whether vapers are using cannabis products. The US Centres for Disease Control and Prevention has urged people not to use e-cigarettes containing THC, some of which contain vitamin E acetate, a “chemical of concern” among people with the vaping-associated lung injury Evali.
Stephen Cooley, chief medical underwriter at PartnerRe Life & Health, says more research on the long-term effects of vaping is needed and that life insurance rates for vapers are the same as smoker rates “at best”.
Munich Re and Gen Re say they are monitoring the recent developments in Evali.
Proponents of vaping as a tool to stop smoking say the insurers’ and reinsurers’ approach is harsh.
“Getting insurance is really expensive for people who have taken steps to quit tobacco,”
says Simon Manthorpe, chief executive of British vaping product manufacturer Vapemate.
Vaping in Britain and elsewhere in Europe is more heavily regulated than in the US. Vapes containing THC or cannabis oil of any kind are banned in Britain, and Public Health England says vaping is at least 95 per cent safer than smoking.
Twelve of 13 life insurers contacted by Reuters in Europe, South Africa and the US say they already treat vaping like smoking.
Most have taken this stance for years, but a handful have recently made the switch to treating vapers like smokers: US insurer Prudential Financial made the change in October, while the Irish subsidiaries of Aviva and Zurich have switched in the past year.
Zurich in Ireland says its new approach followed consultation with reinsurers.
Explaining their caution on vaping, Britain’s Aviva and South Africa’s Discovery say there is a lack of objective evidence of the long-term effects. Justin Harper, head of protection marketing at British insurer LV=, highlights recent evidence indicating that vaping damages the lungs.
Mr Harper says a 20-year policy for a 35-year-old offering £100,000 (Dh475,821) of life cover and £100,000 of critical illness cover would cost £11.89 a month for a non-smoker/non-vaper, and close to twice that figure at £20.56 for a smoker/vaper.
The life insurers told Reuters they were not treating young vapers differently, although Zurich said it was monitoring statistics on increased deaths or illness among this age group.
One exception among the life insurers in its vaping view is Reviti, a new insurer owned by cigarette and e-cigarette manufacturer Philip Morris. It is offering a discount of up to 15 per cent for vapers in Britain. Customers who quit tobacco and nicotine altogether are given a discount of up to 50 per cent.
The shift in reinsurance and insurance is a blow to the vaping industry, which markets its products as healthier than smoking